BridgeMD
New treatment option for Hypertension Disorders in Pregnancy
Official title Vascular Biomarkers Predictive of the Progression From Hypertensive Disorders in Pregnancy to Preeclampsia in Pregnant Women
ClinicalTrials.gov ID: NCT04520048
What this study is testing
- What it's testing
- Hypertension during pregnancy remains a leading cause of maternal and fetal morbidity and mortality. The frequency (5 to 10% of pregnancies) and potential severity of these diseases, both for the mother and the child, are reasons for standardizing and optimizing medical practices.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 40, women only
You may be able to join if
- Patients with a hypertension disorder in pregnancy and/or preeclampsia from the 20th amenorrhea week until the 26th ± 2 amenorrhea week.
- Age between 18 and 40 years old.
- Having given written consent.
- Patients affiliated to a social security scheme.
You likely can't join if
- Presence of pathologies interfering in a major way with vascular parameters: known multicomplicated diabetes treated before pregnancy...
- Cardiac arrhythmia.
- Hepatitis C, HIV infection (assay performed within 6 months prior to diagnosis of pre-eclampsia).
- Recent history of venous (pulmonary embolism, phlebitis) or arterial (myocardial infarction, unstable angina, stroke, transient ischemic attack)...
- Patient already engaged in a therapeutic protocol.
- Patients under legal protective measures.
See the full eligibility criteria
- Patients with a hypertension disorder in pregnancy and/or preeclampsia from the 20th amenorrhea week until the 26th ± 2 amenorrhea week.
- Age between 18 and 40 years old.
- Having given written consent.
- Patients affiliated to a social security scheme.
- Presence of pathologies interfering in a major way with vascular parameters: known multicomplicated diabetes treated before pregnancy, hypercholesterolemia known (or LDL\>130 mg/dl), multicomplicated connectivitis...
- Cardiac arrhythmia.
- Hepatitis C, HIV infection (assay performed within 6 months prior to diagnosis of pre-eclampsia).
- Recent history of venous (pulmonary embolism, phlebitis) or arterial (myocardial infarction, unstable angina, stroke, transient ischemic attack), thrombotic event ≤ 3 months.
- Patient already engaged in a therapeutic protocol.
- Patients under legal protective measures.
- Patients receiving State Medical Assistance.
The study team makes the final eligibility decision.
Where it's taking place
- Bobigny, Seine Saint Denis, France
- Bondy, Seine Saint Denis, France
- Paris, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 40 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bobigny, Seine Saint Denis, France; Bondy, Seine Saint Denis, France; Paris, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.